As a whole, the predictions made by sPLS-DA aligned well with the associated survivability for each tested gene, especially at early LUAD stage-stage interfaces, such as the LUAD tumor stage 1–2 interface, which includes DAPK2 and PLAC9 (Figure 5A,D). This evidence concerns the gene DAPK2 and neoplasm.